Vimarsana
Biggest News Aggregation in the World

Falk Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Falk Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Falk Center Today - Breaking & Trending Today

Summer research leads students to investigate cults, Cape Cod and more - Vimarsana News

Summer research leads students to investigate cults, Cape Cod and more

While many Northwestern students this summer might find themselves stuck in traffic commuting to their office internship, bunking in the middle of the woods at summer camp jobs or catching up with hometown friends by the beach, Communication junior Brady Meldorf is spending his break researching cults. Using funding from a Summer Undergraduate Research Grant,...

NU researchers discover treatment for rare autism subtype - Vimarsana News

NU researchers discover treatment for rare autism subtype

A new therapy could treat Phelan-McDermid syndrome, a rare subtype of autism spectrum disorder, according to a December study by a group of Northwestern researchers. Before the study, there was no drug or therapy specifically designed to treat patients with Phelan-McDermid syndrome. The new therapeutic drug addresses cognitive function and motor behavior deficiencies, among other...

GHP Noetic Science-Psychedelic Pharma Inc. Provides Update on Its Qualifying Transaction with Diamond Therapeutics Inc. - Vimarsana News

GHP Noetic Science-Psychedelic Pharma Inc. Provides Update on Its Qualifying Transaction with Diamond Therapeutics Inc.

TORONTO, ON / ACCESSWIRE / October 7, 2021 / GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) ("GHP"), a Capital Pool Company listed on the TSX Venture Exchange (the "Exchange"), is pleased to

Diamond Therapeutics Appoints Renowned Psychiatrist and Author Dr. Torsten Passie to Scientific Advisory Board - Vimarsana News

Diamond Therapeutics Appoints Renowned Psychiatrist and Author Dr. Torsten Passie to Scientific Advisory Board

/PRNewswire/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic therapies for use in the treatment of mental...